Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Rodby

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 26, 2008
Accelerated venovenous hemofiltration: early technical and clinical experienceCasey N Gashti, Susana Salcedo, Virginia Robinson, et al.
Blood Purification|August 26, 2011
Effects of high blood flow and high pre-dilution replacement fluid rates on small solute clearances in hemofiltrationCasey N Gashti, Roger A Rodby, Zhongping Huang, et al.
American Journal of Nephrology|January 17, 2021
Percutaneous Renal Biopsy Using an 18-Gauge Automated Needle Is Not OptimalGeorge Sousanieh, William L Whittier, Roger A Rodby, et al.
Clinical Kidney Journal|February 11, 2022
Successful treatment of refractory hypertension with bilateral nephrectomy in a patient with chronic kidney disease stage 3Anna M Zemke, Roger A Rodby, Martin Hertl, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settingsAndrew J Palmer, Lieven Annemans, Stephane Roze, et al.
The Journal of Rheumatology|August 19, 2010
LupusQoL-US benchmarks for US patients with systemic lupus erythematosusMeenakshi Jolly, Simon A Pickard, Rachel A Mikolaitis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2008
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USAAndrew J Palmer, William J Valentine, Roland Chen, et al.
Drugs in R&D|August 5, 2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial DataRoger A Rodby, Kausik Umanath, Robert Niecestro, et al.
Radiology|November 10, 2020
Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney FoundationJeffrey C Weinreb, Roger A Rodby, Jerry Yee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2012
Accuracy of a GFR estimating equation over time in people with a wide range of kidney functionSmita Padala, Hocine Tighiouart, Lesley A Inker, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 26, 2008
Accelerated venovenous hemofiltration: early technical and clinical experienceCasey N Gashti, Susana Salcedo, Virginia Robinson, et al.
Blood Purification|August 26, 2011
Effects of high blood flow and high pre-dilution replacement fluid rates on small solute clearances in hemofiltrationCasey N Gashti, Roger A Rodby, Zhongping Huang, et al.
American Journal of Nephrology|January 17, 2021
Percutaneous Renal Biopsy Using an 18-Gauge Automated Needle Is Not OptimalGeorge Sousanieh, William L Whittier, Roger A Rodby, et al.
Clinical Kidney Journal|February 11, 2022
Successful treatment of refractory hypertension with bilateral nephrectomy in a patient with chronic kidney disease stage 3Anna M Zemke, Roger A Rodby, Martin Hertl, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settingsAndrew J Palmer, Lieven Annemans, Stephane Roze, et al.
The Journal of Rheumatology|August 19, 2010
LupusQoL-US benchmarks for US patients with systemic lupus erythematosusMeenakshi Jolly, Simon A Pickard, Rachel A Mikolaitis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2008
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USAAndrew J Palmer, William J Valentine, Roland Chen, et al.
Drugs in R&D|August 5, 2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial DataRoger A Rodby, Kausik Umanath, Robert Niecestro, et al.
Radiology|November 10, 2020
Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney FoundationJeffrey C Weinreb, Roger A Rodby, Jerry Yee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2012
Accuracy of a GFR estimating equation over time in people with a wide range of kidney functionSmita Padala, Hocine Tighiouart, Lesley A Inker, et al.
Pageof 3